LexDanaLexDanabeta
Inventor

Jiwen ZOU

Inventor
US

Overview

2→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes20%
PatentTitleYear
11,731,986Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof202311,220,486Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (2)· patent assignee history
2022Patents assigned to LA JOLLA INST OF ALLERGY & IMMUNOLOGY (1)· patent assignee history
2022–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST22022–2023
LA JOLLA INST OF ALLERGY & IMMUNOLOGY12022
Locations
LocationPatentsSpan
US22022–2023